Literature DB >> 32863291

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia.

Shizuya Yamashita1, Daisaku Masuda1, Masahiro Akishita2, Hidenori Arai3, Yujiro Asada4, Kazushige Dobashi5, Kensuke Egashira6, Mariko Harada-Shiba7, Kenichi Hirata8, Shun Ishibashi9, Kouji Kajinami10, Makoto Kinoshita11, Koichi Kozaki12, Masafumi Kuzuya13, Masatsune Ogura14, Tomonori Okamura15, Kayoko Sato16, Hitoshi Shimano17, Kazuhisa Tsukamoto18, Masayuki Yokode19, Koutaro Yokote20, Masayuki Yoshida21.   

Abstract

Entities:  

Keywords:  Clinical Evaluation; Guidelines; Japanese; LDL-C; Medicinal Products; Treatment of Dyslipidemia

Year:  2020        PMID： 32863291      PMCID： PMC7803830          DOI： 10.5551/jat.CR004

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  6 in total

1.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

3.  Chapter 1 Frailty: Definition, diagnosis, epidemiology.

Authors:  Shosuke Satake; Hidenori Arai
Journal:  Geriatr Gerontol Int       Date:  2020-02       Impact factor: 2.730

Review 4.  Development of a new Japanese guideline on drug interaction for drug development and appropriate provision of information.

Authors:  Akihiro Ishiguro; Reiko Sato; Naomi Nagai
Journal:  Drug Metab Pharmacokinet       Date:  2019-12-20       Impact factor: 3.614

5.  Guidance for Pediatric Familial Hypercholesterolemia 2017.

Authors:  Mariko Harada-Shiba; Takao Ohta; Akira Ohtake; Masatsune Ogura; Kazushige Dobashi; Atsushi Nohara; Shizuya Yamashita; Koutaro Yokote
Journal:  J Atheroscler Thromb       Date:  2018-02-06       Impact factor: 4.928

6.  Statin Intolerance Clinical Guide 2018.

Authors:  Kouji Kajinami; Kazuhisa Tsukamoto; Shinji Koba; Ikuo Inoue; Masashi Yamakawa; Shigeaki Suzuki; Tadanori Hamano; Hidetsugu Saito; Yoshiro Saito; Satohiro Masuda; Takeo Nakayama; Tomonori Okamura; Shizuya Yamashita; Tatehiro Kagawa; Junji Kaneyama; Akira Kuriyama; Rumi Tanaka; Aya Hirata
Journal:  J Atheroscler Thromb       Date:  2019-10-04       Impact factor: 4.928
  6 in total
  1 in total

1.  Changes in Serum Cholesterol in Childhood and its Tracking to Adulthood.

Authors:  Kazushige Dobashi
Journal:  J Atheroscler Thromb       Date:  2021-02-21       Impact factor: 4.928
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.